Taiwan Bio Therapeutics Co., Ltd (TPEX:6892)
Taiwan · Delayed Price · Currency is TWD 27.00
+2.65 (10.88%)
Apr 29, 2026, 1:36 PM CST
Taiwan Bio Therapeutics Market Cap
Taiwan Bio Therapeutics has a market cap or net worth of 2.06 billion as of April 29, 2026. Its market cap has decreased by -29.83% in one year.
Market Cap
2.06B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
27.00
Market Cap Chart
Since May 13, 2022, Taiwan Bio Therapeutics's market cap has increased from 1.93B to 2.06B, an increase of 6.68%. That is a compound annual growth rate of 1.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 2.06B | -14.56% |
| Dec 31, 2025 | 2.41B | -31.88% |
| Dec 31, 2024 | 3.54B | 103.07% |
| Dec 29, 2023 | 1.74B | 7.86% |
| Dec 30, 2022 | 1.62B | -16.32% |
| May 13, 2022 | 1.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G&E Herbal Biotechnology | 2.23B |
| Chunghwa Chemical Synthesis & Biotech | 2.18B |
| Genomics BioSci & Tech. | 2.17B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.11B |
| Sunny Pharmtech | 2.08B |
| TaiRx | 2.06B |
| Anti-Microbial Savior BioteQ | 2.00B |
| Synbio Tech | 1.96B |